Hoornaert, C. J., Luyckx, E., Reekmans, K., Dhainaut, M., Guglielmetti, C., Le Blon, D., Dooley, D., Fransen, E., Daans, J., Verbeeck, L., Quarta, A., De Vocht, N., Lemmens, E., Goossens, H., Van der Linden, A., Roobrouck, V. D., Verfaillie, C., Hendrix, S., Moser, M., Berneman, Z. N., & Ponsaerts, P. (n.d.). in Vivo Interleukin‐13‐Primed Macrophages Contribute to Reduced Alloantigen‐Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants. Stem cells, 34, 1971–1984. http://access.bl.uk/ark:/81055/vdc_100034751429.0x00001c